Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of smoking on the dose-response of ciprofol plus alfentanil for painless gastroscopy
ChiCTR2400079337Phase 4Not yet recruiting
- Sponsor
- Baoding No. 1 Central Hospital
- Start
- Jan 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and alfentanil in None (2 arms), sponsored by Baoding No. 1 Central Hospital. Primary endpoint: Median effective dose. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
ciprofolalfentanil
Beyond the preview
Go deeper on ChiCTR2400079337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079337.